Liquid chromatographic-tandem mass spectrometric method for the simultaneous quantitation of telmisartan and hydrochlorothiazide in human plasma.
Tingting Yan,Hao Li,Lili Deng,Yingjie Guo,Weisong Yu,J Paul Fawcett,Dan Zhang,Yimin Cui,Jingkai Gu
DOI: https://doi.org/10.1016/j.jpba.2008.08.021
IF: 3.571
2008-01-01
Journal of Pharmaceutical and Biomedical Analysis
Abstract:A rapid and sensitive method using liquid chromatography–tandem mass spectrometry (LC–MS/MS) has been developed for the simultaneous determination of telmisartan and hydrochlorothiazide in human plasma. Sample preparation involved liquid–liquid extraction with diethyl ether–dichloromethane (60:40, v/v). The analytes and internal standard, probenecid, were separated on a Venusil XBP-C8 column using gradient elution with acetonitrile–10mM ammonium acetate–formic acid at a flow rate of 1.2mL/min. Detection was by electrospray negative ionization mass spectrometry using multiple reaction monitoring of the transitions at m/z 513.0→469.4 for telmisartan, m/z 295.9→268.9 for hydrochlorothiazide and m/z 283.9→239.9 for probenecid. For both analytes, the method was linear in the range 1.00–600ng/mL with intra- and inter-day precision (as relative standard deviation) ≤10.6% and accuracy (as relative error) ≤4.2%. The assay was successfully applied to a pharmacokinetic study in 9 healthy volunteers given a single oral dose of a combination tablet containing telmisartan 80mg and hydrochlorothiazide 12.5mg.